SuperworthAgilent Technologies EPS A
Diluted earnings per share by quarter and over the last twelve months, from 2008.
- Last 12 months, to Jul 31, 2026
- $5.09
- Latest quarter, Q3 FY26
- $1.28
- +8% on a year earlier
- Fiscal year 2025
- $4.58
- +3% on the year before
Agilent Technologies' earnings per share was $5.09 over the twelve months to Jul 31, 2026, up 19% on a year earlier.
In its latest quarter, Q3 FY26, it was $1.28, up 8% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 15% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $4.58 | +3% |
| FY2024 | $4.43 | +6% |
| FY2023 | $4.19 | +0% |
| FY2022 | $4.18 | +6% |
| FY2021 | $3.93 | +71% |
| FY2020 | $2.30 | −32% |
| FY2019 | $3.36 | +243% |
| FY2018 | $0.98 | −53% |
| FY2017 | $2.10 | +50% |
| FY2016 | $1.40 | +17% |
| FY2015 | $1.20 | −19% |
| FY2014 | $1.49 | −29% |
| FY2013 | $2.11 | −35% |
| FY2012 | $3.26 | +15% |
| FY2011 | $2.83 | +47% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q3 FY26 | $1.28 | +8% | $5.09 | |
| Q2 FY26 | $1.20 | +60% | $4.99 | |
| Q1 FY26 | $1.07 | −4% | $4.54 | |
| Q4 FY25 | $1.54 | +25% | $4.58 | |
| Q3 FY25 | $1.18 | +22% | $4.27 | |
| Q2 FY25 | $0.75 | −29% | $4.06 | |
| Q1 FY25 | $1.11 | −6% | $4.36 | |
| Q4 FY24 | $1.23 | −23% | $4.43 | |
| Q3 FY24 | $0.97 | +155% | $4.80 | |
| Q2 FY24 | $1.05 | +3% | $4.21 | |
| Q1 FY24 | $1.18 | −1% | $4.18 | |
| Q4 FY23 | $1.60 | +29% | $4.19 |
Against its peers
Companies in Medical - Diagnostics & Research nearest Agilent Technologies' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| AAgilent Technologies | $5.09 | +19% a year |
| IQVIQVIA | $8.06 | +17% a year |
| WATWaters | $4.01 | −64% a year |
| IDXXIDEXX Laboratories | $14.22 | +18% a year |
| ILMNIllumina | $5.38 | −32% a year |
| MTDMettler-Toledo International | $44.42 | +12% a year |
| DGXQuest Diagnostics | $9.41 | +18% a year |
| LHLabcorp | $12.09 | +33% a year |
| MEDPMedpace | $17.05 | +27% a year |
| RVTYRevvity | $2.10 | −11% a year |
| DHRDanaher | $5.63 | +20% a year |
| Peer median | $8.73 |
Where Agilent Technologies ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Agilent Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.